Patent · US Active

Fluid infusion system that automatically determines and delivers a correction bolus

US10894126B2 · kind B2 · utility

0Cited by
101References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2019
Grant dateJan 19, 2021
Priority date
Expiry dateJul 18, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2230/201
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method of controlling an insulin infusion device involves controlling the device to operate in an automatic basal insulin delivery mode, obtaining a blood glucose measurement for the user, and initiating a correction bolus procedure when: the measurement exceeds a correction bolus threshold value; and a maximum basal insulin infusion rate is reached during the automatic basal insulin delivery mode. The correction bolus procedure calculates an initial correction bolus amount, and scales the initial amount to obtain a final correction bolus amount, such that a predicted future blood glucose level resulting from simulated delivery of the final correction bolus amount exceeds a low blood glucose threshold level. The final amount is delivered to the user during operation in the automatic basal insulin delivery mode.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.